Who Owns ASBPW?

Aspire Biopharma Holdings, Inc. Warrant — Institutional Ownership & 13F Holdings

$0.02

-0.00 (-16.16%)

Market Cap

$6.2M

Shares Outstanding

345,055,200

Institutional Holders

28

Total Inst. Value

$22.4B

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1CLEAR STREET LLC$22.4B331,064
2HIGHBRIDGE CAPITAL MANAGEMENT LLC$101K1,493,763
3Saba Capital Management, L.P.$72K983,603
4ADAGE CAPITAL PARTNERS GP, L.L.C.$71K1,050,000
5LINDEN ADVISORS LP$66K899,999
6ARISTEIA CAPITAL, L.L.C.$50K681,516
7BARCLAYS PLC$31K350,000
8PERISCOPE CAPITAL INC.$30K408,567
9Verition Fund Management LLC$29K432,757
10Taconic Capital Advisors LP$20K300,000

Related Stocks

Frequently Asked Questions

How many institutional investors hold ASBPW?

As of Q1 2025, 28 institutional investors report holding ASBPW (Aspire Biopharma Holdings, Inc. Warrant) in their 13F filings.

Which hedge fund owns the most ASBPW?

The largest institutional holder of ASBPW is CLEAR STREET LLC with $22.4B in shares.

Are institutions buying or selling ASBPW?

This quarter, 28 institutions opened new positions in ASBPW and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.